Items where Author is "Tyndall, A."
Number of items: 45. 2015Bocelli-Tyndall, C. and Trella, E. and Frachet, A. and Zajac, P. and Pfaff, D. and Geurts, J. and Heiler, S. and Barbero, A. and Mumme, M. and Resink, T. J. and Schaeren, S. and Spagnoli, G. C. and Tyndall, A.. (2015) FGF2 induces RANKL gene expression as well as IL1beta regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells. Annals of the rheumatic diseases, Vol. 74, H. 1. pp. 260-266. 2014Martin, I. and Baldomero, H. and Bocelli-Tyndall, C. and Emmert, M. Y. and Hoerstrup, S. P. and Ireland, H. and Passweg, J. and Tyndall, A.. (2014) The Survey on Cellular and Engineered Tissue Therapies in Europe in 2011. Tissue engineering. Part A, Vol. 20, H. 3-4. pp. 842-853. 2012Martin, I. and Baldomero, H. and Bocelli-Tyndall, C. and Passweg, J. and Saris, D. and Tyndall, A.. (2012) The survey on cellular and engineered tissue therapies in Europe in 2010. Tissue engineering. Part A, Vol. 18, H. 21-22. pp. 2268-2279. 2011Spoerl, D. and Scherer, K. and Tyndall, A.. (2011) Aspects of allergy in rheumatology. Clinical and experimental rheumatology, Vol. 29. pp. 560-566. Daikeler, T. and Tzankov, A. and Hoenger, G. and Gasser, O. and Tyndall, A. and Gratwohl, A. and Hess, C.. (2011) Minimal T-cell requirements for triggering haemophagocytosis associated with Epstein-Barr virus-driven B-cell proliferation : a clinical case study. Annals of the rheumatic diseases, Vol. 70, H. 7. pp. 1338-1339. Avouac, J. and Fransen, J. and Walker, U. A. and Riccieri, V. and Smith, V. and Muller, C. and Miniati, I. and Tarner, I. H. and Randone, S. Bellando and Cutolo, M. and Allanore, Y. and Distler, O. and Valentini, G. and Czirjak, L. and Müller-Ladner, U. and Furst, D. E. and Tyndall, A. and Matucci-Cerinic, M. and Eustar Group, . (2011) Preliminary criteria for the very early diagnosis of systemic sclerosis : results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Annals of the rheumatic diseases, Vol. 70, H. 3. pp. 476-481. Daikeler, T. and Tyndall, A.. (2011) Stammzelltherapie bei Autoimmunerkrankungen = Stem cell treatment of autoimmune disease. Deutsche medizinische Wochenschrift, Jg. 136, H. 33. pp. 1684-1686. Martin, I. and Baldomero, H. and Bocelli-Tyndall, C. and Slaper-Cortenbach, I. and Passweg, J. and Tyndall, A.. (2011) The survey on cellular and engineered tissue therapies in Europe in 2009. Tissue engineering. Part A, Vol. 17, H. 17-18. pp. 2221-2230. Benz, N. and Daikeler, T. and Frank, S. and Mehling, M. and Tyndall, A. and Trendelenburg, M.. (2011) Three cases of primary small vessel vasculitis of the skeletal muscle-an own entity. BMJ case reports, 2011, Nov 8. Hügli, R. W. and Gremmelmaier, D. and Jeanneret, C. and Koella, C. and Jehle, A. W. and Tyndall, A. and Biedermann, B. C.. (2011) Unusual vascular focal high-grade arterial stenoses in a young woman with systemic lupus erythematosus and secondary antiphospholipid syndrome. Lupus, 20 (3). pp. 311-314. Koligi, K. and Mertz, D. and Benz, D. and Vogt, T. and Bloemberg, G. V. and Winter, L. and Tyndall, A. and Battegay, M. and Walker, U. A.. (2011) [Of bugs and joints. Oligoarthritis caused by Tropheryma whipplei]. Der Internist, Vol. 52, no. 7. pp. 884-888. 2010Furst, D. E. and Tyndall, A. and Matucci-Cerinic, M.. (2010) First Systemic Sclerosis World Congress. Clinical and experimental rheumatology, Vol. 28, H. 5, Suppl. 62 , S1-S2. 2009Murigande, C. and Regenass, S. and Wirz, D. and Daniels, A. U. and Tyndall, A.. (2009) A comparison between ((3)H)-thymidine incorporation and isothermal microcalorimetry for the assessment of antigen-induced lymphocyte proliferation. Immunological investigations, Vol. 38. pp. 67-75. Daikeler, T. and Hügle, T. and Farge, D. and Andolina, M. and Gualandi, F. and Baldomero, H. and Bocelli-Tyndall, C. and Brune, M. and Dalle, J. H. and Urban, C. and Ehninger, G. and Gibson, B. and Linder, B. and Lioure, B. and Marmont, A. and Matthes-Martin, S. and Nachbaur, D. and Schuetz, P. and Tyndall, A. and van Laar, J. M. and Veys, P. and Saccardi, R. and Gratwohl, A.. (2009) Allogeneic hematopoietic SCT for patients with autoimmune diseases. Biology of blood and marrow transplantation : official journal of the American Society for Blood and Marrow Transplantation, Vol. 44. pp. 27-33. Miniati, I. and Guiducci, S. and Conforti, M. L. and Rogai, V. and Fiori, G. and Cinelli, M. and Saccardi, R. and Guidi, S. and Bosi, A. and Tyndall, A. and Matucci-Cerinic, M.. (2009) Autologous stem cell transplantation improves microcirculation in systemic sclerosis. Annals of the rheumatic diseases : ARD, Vol. 68. pp. 94-98. Tyndall, A.. (2009) Cellular therapy of systemic lupus erythematosus. Lupus, 18 (5). pp. 387-393. Affolter, B. and Thalhammer, C. and Aschwanden, M. and Glatz, K. and Tyndall, A. and Daikeler, T.. (2009) Difficult diagnosis and assessment of disease activity in giant cell arteritis : a report on two patients. Scandinavian journal of rheumatology, Vol. 38. pp. 393-394. Distler, J. H. and Allanore, Y. and Avouac, J. and Giacomelli, R. and Guiducci, S. and Moritz, F. and Akhmetshina, A. and Walker, U. A. and Gabrielli, A. and Müller-Ladner, U. and Tyndall, A. and Matucci-Cerinic, M. and Distler, O. and Eular, Scleroderma Trials and Research, group. (2009) EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Annals of the rheumatic diseases : ARD, Vol. 68. pp. 163-168. Kowal-Bielecka, O. and Landewé, R. and Avouac, J. and Chwiesko, S. and Miniati, I. and Czirjak, L. and Clements, P. and Denton, C. and Farge, D. and Fligelstone, K. and Földvari, I. and Furst, D. E. and Müller-Ladner, U. and Seibold, J. and Silver, R. M. and Takehara, K. and Toth, B. Garay and Tyndall, A. and Valentini, G. and van den Hoogen, F. and Wigley, F. and Zulian, F. and Matucci-Cerinic, Marco. (2009) EULAR recommendations for the treatment of systemic sclerosis : a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Annals of the rheumatic diseases : ARD, Vol. 68. pp. 620-628. Walker, U. A. and Tyndall, A. and Ruszat, R.. (2009) Erectile dysfunction in systemic sclerosis. Annals of the rheumatic diseases, Vol. 68, H. 7. pp. 1083-1085. Avouac, J. and Kowal-Bielecka, O. and Landewe, R. and Chwiesko, S. and Miniati, I. and Czirjak, L. and Clements, P. and Denton, C. and Farge, D. and Fligelstone, K. and Földvari, I. and Furst, D. E. and Müller-Ladner, U. and Seibold, J. and Silver, R. M. and Takehara, K. and Toth, B. Garay and Tyndall, A. and Valentini, G. and van den Hoogen, F. and Wigley, F. and Zulian, F. and Matucci-Cerinic, M.. (2009) European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis : methods of elaboration and results of systematic literature research. Annals of the rheumatic diseases : ARD, Vol. 68. pp. 629-634. Tyndall, A. and Matucci-Cerinic, M. and Müller-Ladner, U.. (2009) Future targets in the management of systemic sclerosis. Rheumatology, Vol. 48, Suppl. 3 , iii49-53. Walker, U. A. and Tyndall, A. and Czirják, L. and Denton, C. P. and Farge-Bancel, D. and Kowal-Bielecka, O. and Müller-Ladner, U. and Matucci-Cerinic, M.. (2009) Geographical variation of disease manifestations in systemic sclerosis : a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database. Annals of the rheumatic diseases : ARD, Vol. 68. pp. 856-862. Bocelli-Tyndall, C. and Bracci, L. and Schaeren, S. and Feder-Mengus, C. and Barbero, A. and Tyndall, A. and Spagnoli, G. C.. (2009) Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15. Annals of the rheumatic diseases : ARD, Vol. 68. pp. 1352-1359. Tyndall, A. and Pistoia, V.. (2009) Mesenchymal stem cells combat sepsis. Nature medicine, Vol. 15. pp. 18-20. Tyndall, A. and Uccelli, A.. (2009) Multipotent mesenchymal stromal cells for autoimmune diseases : teaching new dogs old tricks. Bone marrow transplantation, Vol. 43, H. 11. pp. 821-828. Hollaender, R. and Hartl, F. and Krieg, M.-A. and Tyndall, A. and Geuckel, C. and Buitrago-Tellez, C. and Manghani, M. and Kraenzlin, M. and Theiler, R. and Hans, D.. (2009) Prospective evaluation of risk of vertebral fractures using quantitative ultrasound measurements and bone mineral density in a population-based sample of postmenopausal women: results of the Basel Osteoporosis Study. Annals of the rheumatic diseases : ARD, Vol. 68. pp. 391-396. Hügle, T. and Gratzl, S. and Daikeler, T. and Frey, D. and Tyndall, A. and Walker, U. A.. (2009) Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced? Annals of the rheumatic diseases : ARD, Vol. 68. pp. 47-50. Wanner, D. P. and Tyndall, A. and Walker, U. A.. (2009) Tenofovir-induced osteomalacia. Clinical and experimental rheumatology : an international journal of rheumatic and connective tissue diseases, Vol. 27. pp. 1001-1003. Matucci-Cerinic, M. and Allanore, Y. and Czirják, L. and Tyndall, A. and Müller-Ladner, U. and Denton, C. and Valentini, G. and Distler, O. and Fligelstone, K. and Tyrrel-Kennedy, A. and Farge, D. and Kowal-Bielecka, O. and van den Hoogen, F. and Cutolo, M. and Sampaio-Barros, P. D. and Nash, P. and Takehara, K. and Furst, D. E.. (2009) The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Annals of the rheumatic diseases : ARD, Vol. 68. pp. 1377-1380. 2008Holbro, A. and Dirnhofer, S. and Went, P. and Tyndall, A. and Daikeler, T.. (2008) Bone marrow histology in a patient with fever of unknown origin. The Journal of rheumatology, Vol. 35. pp. 530-531. Tyndall, A. and Dazzi, F.. (2008) Chronic GVHD as an autoimmune disease. Best practice & research. Clinical haematology, Vol. 21, H. 2. pp. 281-289. Daikeler, T. and Regenass, S. and Tyndall, A. and Gencay, M. M. and Roth, M. and Christ-Crain, M. and Müller, B. and Hess, C.. (2008) Increased serum levels of soluble triggering receptor expressed on myeloid cells-1 in antineutrophil cytoplasmic antibody-associated vasculitis. Annals of the rheumatic diseases, Vol. 67, H. 5. pp. 723-724. Larghero, J. and Farge, D. and Braccini, A. and Lecourt, S. and Scherberich, A. and Foïs, E. and Verrecchia, F. and Daikeler, T. and Gluckman, E. and Tyndall, A. and Bocelli-Tyndall, C.. (2008) Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Annals of the rheumatic diseases : ARD, Vol. 67, H. 4. pp. 443-449. Rovó, A. and Daikeler, T. and Stern, M. and Halter, J. and Studt, J. D. and Buser, A. and Heim, D. and Rischewski, J. and Medinger, M. and Tyndall, A. and Gratwohl, A. and Tichelli, A.. (2008) Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis. Blood, 111. pp. 1740-1741. Aschwanden, M. and Daikeler, T. and Jaeger, K. A. and Thalhammer, C. and Gratwohl, A. and Matucci-Cerinic, M. and Tyndall, A.. (2008) Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease. Annals of the rheumatic diseases, Vol. 67, H. 7. pp. 1057-1059. Walker, U. A. and Tyndall, A. and Daikeler, T.. (2008) Rheumatic conditions in human immunodeficiency virus infection. Rheumatology, Vol. 47, no. 7. pp. 952-959. Solomon, D. H. and Tyndall, A. and Gabriel, S. E. and Dougados, M.. (2008) Rheumatology gone global. Annals of the rheumatic diseases, Vol. 67. p. 1357. Hugle, T. and Schuetz, P. and Mueller, B. and Laifer, G. and Tyndall, A. and Regenass, S. and Daikeler, T.. (2008) Serum procalcitonin for discrimination between septic and non-septic arthritis. Clinical and Experimental Rheumatology, 26 (3). pp. 453-456. van Laar, J. M. and Farge, D. and Tyndall, A.. (2008) Stem cell transplantation: a treatment option for severe systemic sclerosis? Annals of the rheumatic diseases, Vol. 67, Suppl. 3 , iii35-38. Tyndall, A. and Ladner, U. M. and Matucci-Cerinic, M.. (2008) The EULAR Scleroderma Trials and Research Group (EUSTAR) : an international framework for accelerating scleroderma research. Current opinion in rheumatology, Vol. 20, H. 6. pp. 703-706. Seibold, J. R. and Tyndall, A. and Furst, D. E.. (2008) Trial design : how must we move ahead? Rheumatology, Vol. 47, Suppl. 5 , v57-58. Tyndall, A.. (2008) Why do we need noncommercial, investigator-initiated clinical trials? Nature clinical practice. Rheumatology, Vol. 4, H. 7. pp. 354-355. Lüthy, J. and Trampuz, A. and Tyndall, A. and Vogt, T.. (2008) [Spondylodiscitis without fever: a diagnostic challenge]. Deutsche medizinische Wochenschrift, Jg. 133, H. 34-35. pp. 1725-1729. 2007Bocelli-Tyndall, C. and Bracci, L. and Spagnoli, G. and Braccini, A. and Bouchenaki, M. and Ceredig, R. and Pistoia, V. and Martin, I. and Tyndall, A.. (2007) Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Rheumatology, 46 (3). pp. 403-408. |
